Back

CCR2-Overexpressing hydrogelated macrophages facilitate targeted lipid clearance and immunomodulation in atherosclerosis treatment

29 August 2026 (16:15 - 17:00)
Organised by: Logo
Congress Presentation Part of: Atherosclerosis: mechanisms, imaging, and therapeutics Atherosclerosis, Cerebrovascular Diseases, Aneurysm, Restenosis ESC2026 Premium Access ESC Congress 2026 European Society of Cardiology

About the speaker

Photo
Professor Chenghui Yan

General Hospital of Northern Theater Command, Shenyang (China)

6 More presentations in this session

Presentation thumbnail
Nanotheranostics alleviate vulnerable atherosclerotic plaques through lipid-specific photoacoustic imaging and hypoxic microenvironment modulation
Mr Z. Chen (Hangzhou, CN)
Abstract Slides
Presentation thumbnail
Genetic depletion of smooth muscle cells (SMCs) from atheroprogression fundamentally reshapes murine brachiocephalic artery (BCA) lesions
Doctor A. Martinez Navarro (Munich, DE)
Abstract Slides
Presentation thumbnail
PI3 kinase-α protects against vascular inflammation, atherosclerosis, and plaque instability by regulating the biology of vascular smooth muscle cells.
Doctor M. Zierden (Cologne, DE)
Abstract Slides
Presentation thumbnail
The asialoglycoprotein receptor 1, the glycome, and proteome associate with coronary atherosclerosis progression on serial photon-counting coronary computed tomography angiography
Doctor N. Wattchow (Adelaide, AU)
Abstract Slides
Presentation thumbnail
Elevated remnant cholesterol explains a substantial part of excess cardiovascular risk in the metabolic syndrome
Doctor K. Hvid (Herlev, DK)
Abstract Slides

Access the full session

Session thumbnail
Atherosclerosis: mechanisms, imaging, and therapeutics

The Event

Event poster

ESC Congress 2026

29 August 2026 16:15 CET
You may be interested in
thumbnail
Congress Presentation
Human atherosclerotic plaque macrophages associate with clinical presentation and follow diverse lineage differentiation routes
13 April 2024
thumbnail
Congress Presentation
Vascular inflammation in patients undergoing CD19 chimeric antigen receptor (CAR)-T cells for hematologic malignancies: a call for cardiovascular surveillance.
21 June 2025
thumbnail
Congress Presentation
KAND567, the first selective small molecule CX3CR1 antagonist in clinical development, mediates anti-inflammatory cardioprotective effects in rodent models of atherosclerosis and myocardial infarction
3 September 2019
thumbnail
Congress Presentation
HDL-associated phosphatidylserine normalizes vessel wall metabolism and architecture in atherosclerosis
1 September 2025

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources